Clinical Focus Series®


Book Description

This book is a comprehensive assessment of the patients with COPD and asthma with appropriate diagnosis and management. Review on the diagnosis and management of the patients with bronchiectasis and cystic fibrosing along with the current management of acute exacerbation. A discussion of the diagnosis and management of the patients with idiopthic pulmonary fibrosis and an acute exacerbation and the management options those are currently available. Extensive reviews of the treatment of acute pulmonary exacerbation of sarcoidosis and the three phases of hypersensitivity pneumonitis (acute, subac.










Disease Control Priorities in Developing Countries


Book Description

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.




Acute Exacerbations of Pulmonary Diseases


Book Description

The field of acute exacerbations in chronic respiratory disease is challenging: definitions of acute exacerbations differ amongst the diseases and their severity has proven difficult to define. The Guest Editors of this Monograph tackle this challenging area by bringing together articles from internationally recognised experts in the field of acute exacerbations in chronic lung diseases. The book is separated into three sections: the first considers the definition, severity and consequences of exacerbations in each disease; the second looks at exacerbation triggers; and the third discusses the treatment and prevention of exacerbations using pharmacological and non-pharmacological interventions. The book’s structure allows comparisons between the definitions, short- and long-term consequences, triggers and therapeutic management of different respiratory diseases. It serves as a complete reference that raises awareness about the importance of acute exacerbations in patients with chronic lung diseases.




Disease Control Priorities, Third Edition (Volume 5)


Book Description

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.




Chronic Obstructive Pulmonary Disease Exacerbations


Book Description

Chronic Obstructive Pulmonary Disease Exacerbations covers the definition, diagnosis, epidemiology, mechanisms, and treatment associated with COPD exacerbations. This text also addresses imaging and how it plays a pivotal role in the diagnosis and study of exacerbations.Written by today's top experts, Chronic Obstructive Pulmonary Disease Exacerbat




Clinical Focus Series


Book Description

The purpose of this book is to provide medical students, postgraduate fellows, general practitioners and specialists a succinct, easy to read, well-illustrated and comprehensive review of interstitial disorders encountered in clinical practice. Authored by a team of internationally recognized experts, the chapters cover different aspects of these complex maladies and suggest plans for effective management of patients with diffuse parenchymal disease. The book opens with a brief historical account followed by physiological and radiological features of interstitial lung diseases. Each concise ch.




Clinical Manifestations & Assessment of Respiratory Disease - E-Book


Book Description

**Selected for Doody's Core Titles® 2024 in Pulmonology** A realistic look at treating respiratory diseases! Clinical Manifestations and Assessment of Respiratory Disease, 9th Edition gives you the fundamental knowledge and understanding required to successfully assess and treat patients with respiratory diseases. This foundation helps you learn how to systematically gather relevant clinical data; make an objective evaluation; identify the desired outcome and formulate an assessment; design a safe, appropriate, and effective treatment plan; and document all the steps involved. With this knowledge, you will understand the effectiveness of performing therapies and when to adjust therapy to a desired outcome. - UNIQUE! Emphasis on clinical scenarios and critical thinking skills prepares you for real-world practice. - UNIQUE! Focus on assessment and Therapist Driven Protocols (TDPs). - UNIQUE! Overview boxes highlight the clinical manifestations for each disease. - Logically organized content is written at a user-friendly, approachable reading level for ease of use and understanding. - Case studies provide realistic examples of the respiratory therapy practitioner's role in successful patient care. - End-of-chapter self-assessment questions and answer key are available on the companion Evolve website. - NEW! Clinical Connection boxes provide real-world clinical case studies in relevant chapters. - NEW! An updated design and additional tables, boxes, and figures draw attention to key information. - UPDATED! Content includes the latest developments related to SARS and COVID-19. - UPDATED! Information on ventilators, usage, and protocols reflects current practice. - NEW! QR codes in most chapters direct to additional outside content to enhance the chapter, including audio sounds and animations.




A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases


Book Description

Chronic diseases are common and costly, yet they are also among the most preventable health problems. Comprehensive and accurate disease surveillance systems are needed to implement successful efforts which will reduce the burden of chronic diseases on the U.S. population. A number of sources of surveillance data-including population surveys, cohort studies, disease registries, administrative health data, and vital statistics-contribute critical information about chronic disease. But no central surveillance system provides the information needed to analyze how chronic disease impacts the U.S. population, to identify public health priorities, or to track the progress of preventive efforts. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases outlines a conceptual framework for building a national chronic disease surveillance system focused primarily on cardiovascular and chronic lung diseases. This system should be capable of providing data on disparities in incidence and prevalence of the diseases by race, ethnicity, socioeconomic status, and geographic region, along with data on disease risk factors, clinical care delivery, and functional health outcomes. This coordinated surveillance system is needed to integrate and expand existing information across the multiple levels of decision making in order to generate actionable, timely knowledge for a range of stakeholders at the local, state or regional, and national levels. The recommendations presented in A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases focus on data collection, resource allocation, monitoring activities, and implementation. The report also recommends that systems evolve along with new knowledge about emerging risk factors, advancing technologies, and new understanding of the basis for disease. This report will inform decision-making among federal health agencies, especially the Department of Health and Human Services; public health and clinical practitioners; non-governmental organizations; and policy makers, among others.